-Search query
-Search result
Showing 1 - 50 of 1,036 items for (author: daniel & gr)
EMDB-45005:
Paired Helical Filament of tau amyloids found in Down Syndrome individuals
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
EMDB-45007:
Straight Filament of tau amyloids found in Down Syndrome individuals
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
EMDB-45008:
Paired Helical Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
EMDB-45009:
Straight Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
PDB-9bxi:
Paired Helical Filament of tau amyloids found in Down Syndrome individuals
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
PDB-9bxo:
Straight Filament of tau amyloids found in Down Syndrome individuals
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
PDB-9bxq:
Paired Helical Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
PDB-9bxr:
Straight Filaments purified from Down Syndrome individual brain tissue applied to graphene oxide antibody affinity grids
Method: helical / : Tse E, Ghosh U, Condello C, Southworth D
EMDB-50580:
SOLIST cryo-tomogram of native left ventricle mouse heart muscle #1
Method: electron tomography / : Erdmann PS, Nguyen HTD, Perone G, Klena N, Vazzana R, Kaluthantrige Don F, Silva M, Sorrentino S, Swuec P, Leroux F, Kalebic N, Coscia F
EMDB-50582:
SOLIST native mouse heart muscle tomogram #2
Method: electron tomography / : Erdmann PS, Nguyen HTD, Perone G, Klena N, Vazzana R, Kaluthantrige Don F, Silva M, Sorrentino S, Swuec P, Leroux F, Kalebic N, Coscia F
EMDB-19163:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
EMDB-19164:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
EMDB-19165:
Trimeric HSV-2F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
EMDB-19166:
Trimeric HSV-2G gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
PDB-8rgz:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
PDB-8rh0:
Trimeric HSV-1F gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
PDB-8rh1:
Trimeric HSV-2F gB ectodomain in postfusion conformation with three bound HDIT101 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
PDB-8rh2:
Trimeric HSV-2G gB ectodomain in postfusion conformation with three bound HDIT102 Fab molecules.
Method: single particle / : Kalbermatter D, Seyfizadeh N, Imhof T, Ries M, Mueller C, Jenner L, Blumenschein E, Yendrzheyevskiy A, Moog K, Eckert D, Engel R, Diebolder P, Chami M, Krauss J, Schaller T, Arndt M
EMDB-16375:
SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody
Method: single particle / : Das H, Hallberg BM
PDB-8c0y:
SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody
Method: single particle / : Das H, Hallberg BM
EMDB-43712:
Human EBP complexed with compound 1
Method: single particle / : Sun D, Masureel M
EMDB-43713:
Human EBP complexed with compound 3a
Method: single particle / : Sun D, Masureel M
PDB-8w0r:
Human EBP complexed with compound 1
Method: single particle / : Sun D, Masureel M
PDB-8w0s:
Human EBP complexed with compound 3a
Method: single particle / : Sun D, Masureel M
EMDB-42074:
Representative tomogram of Enterococcus faecium WT Com15
Method: electron tomography / : Hang HC, Park D
EMDB-42086:
Representative tomogram of Enterococcus faecium SagA complementation strain
Method: electron tomography / : Hang HC, Park D
EMDB-42087:
Representative tomogram of Enterococcus faecium SagA deletion strain
Method: electron tomography / : Hang HC, Park D
EMDB-19014:
PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Drulyte I, Hurdiss DL
EMDB-19015:
Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Hurdiss DL
EMDB-19016:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Hurdiss DL
EMDB-19017:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Drulyte I, Hurdiss DL
PDB-8r9w:
PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Hurdiss DL
PDB-8r9x:
Local refinement of the PDCoV spike glycoprotein ectodomain in complex with the 22C10 antibody Fab fragment
Method: single particle / : Debski-Antoniak O, Hurdiss DL
PDB-8r9y:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 42H3 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Hurdiss DL
PDB-8r9z:
S1B domain of the PDCoV spike glycoprotein in complex with the 67B12 and 46E6 antibody Fab fragments
Method: single particle / : Debski-Antoniak O, Hurdiss DL
EMDB-18051:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18052:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18054:
Inward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18055:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18057:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18059:
Outward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18066:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18067:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18068:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18069:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18138:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18139:
Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18140:
Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18141:
Outward-facing, closed proteoliposome complex I at 2.5 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18142:
Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
Pages: